Target intelligence / Profile preview

Intestinal mucosal surface and stool matrix

Molecular classification
Other
01

Overview

The intestinal mucosal surface and stool matrix represent a complex biological environment rather than a single molecular target. The mucosal surface consists of a protective mucus layer, primarily composed of MUC2 mucin glycoproteins, and the underlying epithelial cells that facilitate nutrient absorption and provide a barrier against pathogens (Johansson et al., 2011). The stool matrix is a heterogeneous mixture of undigested dietary components, water, and a dense population of commensal and potentially pathogenic microorganisms (Fallingborg, 1999). This compartment is the primary site of action for non-absorbable drugs, such as certain antibiotics, phosphate binders, and secretagogues, which aim to treat local infections, manage metabolic waste, or modulate intestinal motility (Pimentel, 2016). While critical for gastrointestinal health and drug delivery, it is considered a physiological site or compartment in pharmacological terms rather than a specific receptor or enzyme.

Other names
Gut lumenIntestinal lumenFecal matrixGastrointestinal mucus layerIntestinal mucosal interface
02

Mechanism of action

Drugs targeting this environment typically act through local antimicrobial activity, physical sequestration of ions or toxins, or by modulating the osmotic gradient and mucosal signaling without significant systemic absorption.

03

Biological functions

Barrier functionMicrobiome habitatWaste eliminationNutrient absorptionWater reabsorption
04

Disease associations

Gastrointestinal infectionInflammatory bowel diseaseDysbiosisMalabsorptionChronic kidney disease (via phosphate binding)
05

Safety considerations

Alteration of gut microbiotaGastrointestinal distressPotential for unintended systemic absorptionInterference with absorption of other medications
06

Interacting drugs

Rifaximin

5 more in the full profile.

07

Biomarkers

Fecal calprotectinFecal occult bloodMicrobiome diversity indexFecal elastase

Beyond the preview

Go deeper on Intestinal mucosal surface and stool matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal mucosal surface and stool matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call